Quote | Synairgen PLC Ord (OTCMKTS:SYGGF)
Last: | $0.0565 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0565 |
Close: | $0.0565 |
High: | $0.0565 |
Low: | $0.0565 |
Volume: | 2,000 |
Last Trade Date Time: | 07/09/2024 03:00:00 am |
News | Synairgen PLC Ord (OTCMKTS:SYGGF)
(NewsDirect) Synairgen PLC (AIM:SNG, OTC:SYGGF) chief executive Richard Marsden speaks to Thomas Warner from Proactive London about the company's ongoing efforts to develop what he describes as a "drug to help patients handle respiratory viruses." He explains that work on the drug lon...
(NewsDirect) Synairgen PLC (AIM:SNG, OTC:SYGGF) chief executive Richard Marsden talks to Proactive following the release of full year results for calendar year 2022 - a year he says was "quite challenging at times." Marsden discusses the UK-based respiratory company's clinical development...
Message Board Posts | Synairgen PLC Ord (OTCMKTS:SYGGF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
(NewsDirect) Synairgen PLC (AIM:SNG, OTC:SYGGF) chief executive Richard Marsden speaks to Thomas Warner from Proactive London about the company's ongoing efforts to develop what he describes as a "drug to help patients handle respiratory viruses." He explains that work on the drug lon...
(NewsDirect) Synairgen PLC (AIM:SNG, OTC:SYGGF) chief executive Richard Marsden talks to Proactive following the release of full year results for calendar year 2022 - a year he says was "quite challenging at times." Marsden discusses the UK-based respiratory company's clinical development...